Skip to content
Project Directory
  • Français
Donate Now
  • Français
  • About
    • What We Do
    • EDI Action Plan
    • Leadership
    • Team
    • Annual Report
    • Publications
    • Careers
  • Brain Conditions
    • One Brain
    • ALS
    • Autism (ASD)
    • Brain Cancer
    • Brain Injury
    • Dementia
    • Epilepsy
    • Mental Illness
    • Multiple Sclerosis
    • Parkinson’s
    • Stroke
    • More
  • Research
    • Programs
    • Funding Opportunities
    • Program Partners
    • Announcements
  • Impact
    • Research Impact Stories
    • Equity, Diversity and Inclusion
    • Brain Health in Indigenous Communities
    • Women’s Brain Health
    • Mind Over Matter
  • How You Can Help
    • Ways to Give
    • Start a Fundraiser
    • Workplace Giving
    • The Great Minds

Funded Grants

Back to results

Harnessing mRNA translation to increase the neuroprotective potential of disease-associated microglia in neurodegenerative diseases

Project Overview

Microglia are the brain’s immune cells. Research in recent years has revealed their crucial role in preventing the development of neurodegenerative diseases, including Alzheimer’s Disease (AD). However, the precise mechanisms by which microglia lose their potency in protecting the brain, enabling the development of AD, are not fully understood. Our research indicates that microglia dysfunction is related to molecular mechanisms responsible for the control of mRNA translation, the key step translating the genetic information stored in the genome to the production of proteins in the cell. Specifically, we discovered how overactivity of 4E-BPs, a family of proteins responsible for repressing mRNA translation, is contributing to this microglia dysfunction and AD progression. Increased levels of 4E-BP in the cerebrospinal fluid of AD patients correlate with more severe symptoms and we showed that genetically depleting 4E-BPs restores the normal function of the microglia cells both in a cell culture and a mouse model. Our goal in this project is to elucidate the molecular mechanisms by which mRNA translation impacts microglial function. By employing state-of-the-art CRISPR screen and other single-cell multiomic technologies we have developed to study biological functions at a single-cell resolution, we seek to identify and target specific mRNA regulators that could restore microglial function and health. The goal is to develop new therapeutic strategies that can halt or even reverse the progression of AD via mechanisms which restore the protective functions of the brain’s immune system. By understanding and manipulating the intricate molecular pathways that control microglia cells, this research could pave the way for significant advancements in AD therapy, opening new avenues to combat AD and similar neurodegenerative diseases.

Principal Investigator

Nahum Sonenberg , McGill University

Project Ongoing

Harnessing mRNA translation to increase the neuroprotective potential of disease-associated microglia in neurodegenerative diseases

  • Grant Type

    Team grants

  • Area of research

    Neurodegeneration

  • Disease Area

    Alzheimer’s

  • Competition

    Brain Canada & Weizmann Institute of Science Team Grants

  • Province

    Québec

  • Start Date

    2024

  • Total Grant Amount

    $500,000

  • Health Canada Contribution

    $250,000

Contact Us

1200 McGill College Avenue
Suite 1600, Montreal, Quebec
H3B 4G7

+1 (514) 989-2989 info@braincanada.ca

Please note all online donations will receive an electronic tax receipt, issued by Brain Canada Foundation.

Our Donors

Playing with Marbles Podcast

Join us and take a journey to the real last great frontier – the brain.

Listen

Subscribe to Brain News

Receive our monthly electronic newsletter with updates on funded projects, upcoming events and breakthroughs in brain research.

Sign Up

Territorial acknowledgement

The offices of Brain Canada Foundation are located on the traditional, ancestral territory of the Kanien'kehá:ka Peoples, a place which has long served as a site of meeting and exchange amongst nations. We honour and pay respect to elders past, present and emerging, and dedicate ourselves to moving forward in the spirit of partnership, collaboration, and reconciliation. In our work, we focus our efforts on the Truth and Reconciliation Commission’s Calls to Action, particularly those that pertain to improving health for Indigenous Peoples and that focus on advancing our own learning on Indigenous issues.

© 2025 Brain Canada Foundation

Registration number: 89105 2094 RR0001

  • Terms and Conditions
  • Privacy Policy

Design by Field Trip & Co

  • About
    • What We Do
    • EDI Action Plan
    • Leadership
    • Team
    • Annual Report
    • Publications
    • Careers
  • Brain Conditions
    • One Brain
    • ALS
    • Autism (ASD)
    • Brain Cancer
    • Brain Injury
    • Dementia
    • Epilepsy
    • Mental Illness
    • Multiple Sclerosis
    • Parkinson’s
    • Stroke
    • More
  • Research
    • Programs
    • Funding Opportunities
    • Program Partners
    • Announcements
  • Impact
    • Research Impact Stories
    • Equity, Diversity and Inclusion
    • Brain Health in Indigenous Communities
    • Women’s Brain Health
    • Mind Over Matter
  • How You Can Help
    • Ways to Give
    • Start a Fundraiser
    • Workplace Giving
    • The Great Minds
Project Directory
Donate Now